MST1 and metabolic dysfunction-associated steatotic liver disease: Building on this, future efforts could engineer humanized organoid models incorporating diverse cell types to recapitulate the complex microenvironment of NAFLD, thereby validating MST1’s regulatory role and bridging foundational research with clinical translation [96].